Omar Abudayyeh
@omarabudayyeh
McGovern Fellow @mcgovernmit by way of @broadinstitute | @harvardmed |@MIT Molecular tool lab. Co-founder @Sherlock_bio & https://t.co/GnLoSlRvsZ & https://t.co/ElMMNGf8bL
ID:18602271
http://Abugoot.mit.edu 04-01-2009 14:07:02
1,7K Tweets
6,5K Followers
2,3K Following
Follow People
Dear fellow Americans. Please read this.
From Noah Smith 🐇🇺🇸🇺🇦.
“Americans are still not worried enough about the risk of world war”
noahpinion.blog/p/americans-ar…
Excited to invite all students to the Harvard OpenBio Laboratory Future of Biology Conference 2024!
We are lucky to have an incredible speaker line-up, incl.:
🧬 - george church (@harvardmed)
🌱 - Reshma Shetty (@Ginkgo)
🦾 - Ritu Raman (@MIT)
🧫 - Jonathan Gootenberg + Omar Abudayyeh (@mcgovernmit)
Stoked about the speaker lineup at this year’s Harvard OpenBio Laboratory conference!
It’s huge to see leading professors like george church Omar Abudayyeh Jonathan Gootenberg in the same place as Gingko co-founder Reshma Shetty and many other seeing speakers.
Register here: docs.google.com/forms/d/e/1FAI…
Announcing
THE STATE OF CRISPR and GENE EDITING
A free virtual summit hosted by Kevin Davies Genetic Engineering & Biotechnology News on June 5.
Confirmed speakers include:
David R. Liu
Laura Sepp-Lorenzino
Sam Sternberg
Joe Bondy-Denomy
Prof Alison Van Eenennaam (@BioBeef)
Patrick Hsu
Omar Abudayyeh
Jonathan Gootenberg
webinars.liebertpub.com/e/the-state-of…
Curious about #CRISPR technology?
CRISPR-based systems are moving lightning-fast, but this review from Nature Reviews Molecular Cell Biology can bring you up to speed.
Explore technological advancements, strengths and weaknesses, and the potential impact on human health.
go.nature.com/430sheV
Another interesting conversation with Tome Biosciences’s CEO & president - Rahul Kakkar about Tome recent exiting stealth mode with $250M in funding, its new platform of CRISPR Gene Editing - programmable genomic integration (PGI) & more. #SundayPodcast $XBI
podcasts.apple.com/il/podcast/bey…
Tome’s CEO, Rahul Kakkar, sat down with Theral Timpson of mendelspod to discuss how genomic-based therapies are crucial in curing diseases versus treating them.
bit.ly/42HeUjC
#CRISPR #genomeediting #TomeBio #genomicmedicine
Wonder what that secretive longevity company funded w/ $3B from Jeff Bezos and Yuri Milner has been working on?
SCOOP: Altos Labs latest public program is an oligonucleotide inhibiting the retrotransposon LINE-1 to treat progeria.
A terrific story of transcultural unity and collaboration in this very challenging time! “Jomar” are THE dynamic duo in genetic medicines! Omar Abudayyeh Jonathan Gootenberg bostonglobe.com/2024/02/12/bus…
A thoughtful write-up from the The Boston Globe on the uniting power of #science , profiling repeat Longwood scientists and entrepreneurs. We’ve thoroughly enjoyed working with Omar Abudayyeh and Jonathan Gootenberg on several #newcos , including Tome Biosciences and Doppler Bio. bostonglobe.com/2024/02/12/bus…
It is wonderful to see former McGovern Fellows Omar Abudayyeh and Jonathan Gootenberg continue their personal and professional partnership beyond MIT.
bostonglobe.com/2024/02/12/bus…
‘RNA writing’ is latest tech to emerge in race to edit large blocks of genetic material. My story for Endpoints News on the method that hijacks RNA splicing to replace swathes of mRNA. Scientists say it's like the RNA version of prime editing or DNA writing. 🧵
endpts.com/rna-writing-is…